Monthly Archives: June 2017

Dr. Cameron Clokie Retires From Academics To Serve At Induce Biologics Inc.

Dr. Cameron Clokie is a renowned entrepreneur and surgeon who reside in Toronto, Canada. Dr. Cameron has dedicated his entire professional life in finding new ways that can bring a positive impact in the oral and maxillofacial fields.

He is extremely knowledgeable and well versed in this field, and he has made numerous discoveries and contributions that have changed the way doctors in the field work. Dr. Cameron Clokie is a well-known individual who is looked upon by professionals from all over the world. He has served in this area for the last three decades. Learn more about Cameron Clokie:

Dr. Cameron Clokie graduated in 1985 with a degree in Dental Surgery. After his undergraduate degree, Cameron Clokie enrolled at McGill University where he earned his Ph.D. Clokie specialized in bone regeneration and dental implants. His tremendous expertise in this field explains why patients from all over the world sought out for his services.

Dr. Cameron has published numerous papers in the field of dental surgery, and he has also conducted lectures around the world teaching on oral healthcare, oral and maxillofacial surgery amongst other dental issues.

During his career, Dr. Cameron has served in the academic dentistry and also in the private practice. At one point in his career, Cameron served as the head of Oral Maxillofacial Surgery at the University of Toronto. Dr. Cameron has also served as a professor at the great University of Toronto until he retired from academics in early 2017. Dr. Cameron has served as a board member for several institutions including private institutions and also in various scientific advisory boards.

 Cameron Clokie successes in his career include securing the approval of various international and the United States patents. As an expert in maxillofacial surgery, Dr, Cameron has devised ways to coax broken or missing bones to re-grow. He has helped several patients who have had their jaw broken or those who have lost their jaws to cancer.

Currently, Dr. Cameron serves as the CEO of Induce Biologics Inc. It is a regenerative medicine firm that focuses on innovative solutions for musculoskeletal reconstruction. Dr. Cameron’s experience coupled with his excellent business acumen has made him a great leader to Induce Biologics Inc.

Read more: Dr. Cameron Clokie – Hospital Information and Nearby Florists

The Global CEO of CP+B, Lori Senecal

In March 2015, Lori Senecal undertook the role of global CEO of MDC Partners Agency CP+B. During this time, it was a new role within the agency. Before that, she had the role of the President and CEO of the company, a position she continued to hold as the global CEO. She has been fruitful in ensuring that the organization can become a global agency, all this has been achieved by making the company nimble and flexible like most entrepreneurial start-ups.

Back in October 2015, a few months after she got the role, she managed to land American Airlines. She was able to snag away the account from their competitor TM advertising with whom the Airlines had worked with for almost 25 years. She has continued to assist in developing the agency and ensuring that they can also gain some leadership team which will have the role of coming up with the company’s future strategies.

In a report by Adweek, since the company has ten offices, the leadership team is assisting in ensuring that all of these offices are taken care of to the liking of the management. Danielle Aldrich is amongst the members of the leadership team, and she has been elevated to being the president of CP+B Boulder and Los Angeles, which joins to form CP+B West. This elevation of the regional leaders has brought about seamless sharing of resources across the offices, thus bringing about more creativity and talent. More so, they have been able to uncover most of the toughest business challenges.

About Lori Senecal

Lori Senecal has been able to build her career as the president and CEO of CP+B; furthermore, her new role as the global CEO has catapulted her to better levels in which she has brought about change to the company.

She is a leader and focused on impacting change within a company. Lori has been able to assist the agency to be among the Creativity Innovators of the Year. Through all this, she has been able to build her career. Before being the President of the agency, she served as a CEO and Global Chairman of KBS.

Follow her on Twitter

Read more:

Capital Group Thriving will others Drown

American icon and investment guru Warren Buffett has made a $1 million dollar gamble, saying he could make better investment returns than a bunch of hedge fund managers by only investing in a S&P 500 passive index fund. The gamble is supposed to pay off for Warren Buffett this year. Warren Buffett says he will donate the winning to charity. Warren Buffett believes that many expensive funds that end up costing investors. Both Tim Armour and Warren Buffett believe low cost and simple investments should be bought and held for a long period of time.


Warren Buffett has become vocal when it comes to “bottom-up” investing which reviews companies and works to build a strong portfolio, which has worked for Warren Buffett for many years. Warren Buffett is encouraging Americans to save more as they near retirement and to invest and stay invested. Warren Buffett penned a letter to shareholders, saying the “active versus passive” debate does not help investors. Buffett has also said that mutual funds offer poor long-run returns because of excessive trading and costly management fees and what Tim Armour knows.


Warren Buffett believes in long-term investment returns that are achieved by having low costs. Tim Armour does not support passive index returns being the key to a prosperous retirement. Warren Buffett has found two ways to identify strong investors, and they are low expensive and high manager ownership.


Timothy Armour is currently the chairman and chief executive officer at The Capital Group. Tim Armour also serves as chairman of the Capital Group Management Company. Tim Armour has been with Capital Group for more than 30 years. Tim Armour started out at Capital Group as par of The Associates Program and later became an equity investment analyst at Capital Group, where he covered global telecommunications and American service companies and Tim’s lacrosse camp.


Tim Armour resides in Los Angeles, California. Timothy Armour received a bachelor’s degree in economics at Middlebury College. Timothy Armour has made a number of appearances on CNBC and MSNBC. Armour has been featured in several financial magazines including Bloomberg and the Financial Times. Tim Armour continues to advise people on investing in the market and more information click here.


The Tempus Initiative and Other Works from Eric Lefkosky

All the medical practitioners that are working in the 21st century dream that this is the time they will manage to beat cancer once and for all. To try and make this dream a reality, there are many steps that they have put in place including the inclusion of technology in cancer research. The Tempus Initiative, which is the brainchild of Eric Lefkosky, is an attempt to make sure that through the use of technology, the quality of care that is given to people that suffer from cancer.

Eric has always been a stronger believer in the fact that the best way to deal with cancer and any of the other progressive illnesses was through genetic sequencing. He believes that when technology is used to track the progress of cancer patients, it will be possible to tell how they will react to certain treatments and to even predict complications even before they occur and look for solutions to them.

He started his journey towards becoming the successful entrepreneur that he is when he was in college. When he was studying law at the University of Michigan, he started a company that was meant to supply upholstery and named it Brandon Apparel. They had gotten the capital they needed to create the business from their close family and friends and more information click here.

The second business that he started came to be known as Innerworkings. It was known as Innerworkings and provided procurement to SMEs. The company held its first IPO in 2012 after growing successfully. At the time when he was still growing this business, he got the idea to start a third business, which he did and named it Echo Global Statistics. The company has its stocks listed on NASDAQ .

Tempus initiative

These are applications that are used by the Doctors and other medical practitioners

together with their patients. Using the applications, the Doctors are able to know the treatments that will work and eliminate those that will not work as they should. When it comes to philanthropy, Lefkosky is a member of the board of the Chicago children’s hospital.

More visit: